能让医生一边做CT或核磁共振检查、一边进行实时图像引导精准监测穿刺角度的微创穿刺手术机器人 平台项目，推动我国实现超高端CT影像设备"弯道超车"和技术跨越的光子CT产业化项目，大大降低辐 射剂量、提高成像分辨率的新一代半导体成像项目……在大赛医疗器械前十强中，一个个实现底层技术 创新、探索生命健康新边界的参赛项目令人应接不暇。 由芯智睿声带来的"可穿戴智能人工喉"项目，能借助纳米级石墨烯柔性传感器、灵敏麦克风等精准捕捉 喉部肌肉的振动及微弱声音信号，再经多模态人工智能算法识别出用户所想讲的话，最后通过音色克隆 及语音还原技术，将信号实时转化为清晰、流畅且富有情感的自然人声。 该公司首席执行官王宇峰介绍，与市面上常见的气动式人工喉和电子喉相比，这款设备不需要植入，可 以直接穿戴使用，减轻患者痛苦，而且在声音输出效果上，一改常见的机械音问题，能够还原用户患病 前的音色。"希望让每个人的声音都被世界听见。"王宇峰说，该产品适用于聋哑人士、渐冻症患者、喉 切除患者、中风后遗症人群、帕金森病患者，以及因年龄增长面临发声困难的老年群体。产品预计在 2026年送检并进入临床、取证阶段，预计于2027年推向市场。 在高度放大 ...

Group 1 - The stock of Zhongguancun (000931) closed at 5.17 yuan on January 22, 2026, with an increase of 1.37% and a turnover rate of 1.68% [1] - The trading volume was 126,400 hands, with a total transaction amount of 65.031 million yuan [1] - On January 22, the net inflow of main funds was 3.0816 million yuan, accounting for 4.74% of the total transaction amount, while retail funds had a net outflow of 4.7124 million yuan, accounting for 7.25% [1] Group 2 - For the first three quarters of 2025, Zhongguancun reported a main operating income of 1.882 billion yuan, a year-on-year decrease of 2.46%, and a net profit attributable to shareholders of 49.4914 million yuan, down 4.14% year-on-year [2] - The third quarter of 2025 saw a single-quarter main operating income of 644 million yuan, a decrease of 1.96% year-on-year, and a net profit attributable to shareholders of 10.6825 million yuan, down 29.9% year-on-year [2] - The company has a debt ratio of 51.09%, with investment income of -1.6826 million yuan and financial expenses of 36.1322 million yuan, while the gross profit margin stands at 59.64% [2] Group 3 - Zhongguancun's main business segments include biopharmaceuticals and health products, elderly medical care, commercial concrete, and other businesses [2] - The biopharmaceutical and health products segment involves the research, manufacturing, and sales of various pharmaceutical forms, including chemical drugs, traditional Chinese medicine, and medical devices [2] - The elderly medical care segment encompasses centralized elderly care services, home care services, health management, and traditional Chinese medical services [2]

Core Insights - The new energy storage industry in China has shown significant growth, with a cumulative installed capacity of 213.3 GW by the end of 2025, representing a year-on-year increase of 54% [2] - The market share of energy storage technology has diversified, with pumped storage accounting for 31.3% and new energy storage, led by lithium batteries, exceeding two-thirds of the total installed capacity [2] - The installed capacity of new energy storage reached 144.7 GW by the end of 2025, marking an 85% year-on-year increase and a 45-fold increase compared to the end of the 13th Five-Year Plan [2] Market Trends - In 2025, new energy storage added 66.43 GW/189.48 GWh, with power and energy scales growing by 52% and 73% year-on-year, respectively [3] - The top 10 provinces in terms of installed capacity each exceeded 5 GWh, collectively accounting for nearly 90% of the total, with Inner Mongolia leading in both energy and power installations [3] - The number of bidding sections for energy storage systems decreased by 10.4% to 690, while EPC bidding sections increased by 4.5% to 1,536, indicating a shift towards integrated delivery and risk outsourcing [3] Pricing and Procurement - The bidding scale for energy storage systems (excluding collective procurement) reached 121.5 GWh in 2025, a 140.1% increase year-on-year, while EPC bidding scale was 206.3 GWh, up 125.5% [4] - The average bidding price for energy storage systems showed a downward trend, with prices for lithium iron phosphate systems ranging from 391.14 to 913.00 yuan/kWh, and EPC average prices decreasing by 13.04% and 8.19% for 2h and 4h systems, respectively [4] Future Outlook - The new energy storage market is expected to move towards marketization, particularly in commercial and industrial sectors, with anticipated growth in installed capacity to over 30 GW by the end of the 14th Five-Year Plan [5] - The development of new energy storage will be driven by market forces, with a focus on expanding application scenarios and innovative business models during the 14th Five-Year Plan [6] - The average duration of new energy storage installations is projected to increase from 2.58 hours in 2025 to 3.47 hours by 2030, reflecting advancements in technology and growing market demand for long-duration storage [7]

Core Viewpoint - The article highlights the rapid development and collaborative innovation taking place in the Xiong'an New Area's Zhongguancun Science Park, emphasizing the integration of technology and services to support startups and established companies in the region [1][12][28]. Group 1: Innovation and Development - The Xiong'an New Area Zhongguancun Science Park has attracted over 200 companies within two years, showcasing strong collaborative innovation vitality [1][12]. - The park features a comprehensive service center with 33 service institutions providing "one-stop" services for businesses, facilitating everything from registration to project implementation [8][12]. - The park's ecosystem focuses on AI technologies, enabling advancements in healthcare, education, and other sectors through a full-stack AI approach [6][12]. Group 2: Collaborative Models - Many companies in the park have relocated from Beijing, utilizing a collaborative model where research is conducted in Beijing and applications are implemented in Xiong'an [6][17]. - The integration of services includes tailored financial products to address specific challenges faced by companies, such as the "relocation loan" designed to assist businesses in securing funding [9][12]. - The collaborative innovation model is further enhanced by joint research projects among institutions in Beijing, Tianjin, and Hebei, breaking down regional barriers and creating a more efficient innovation ecosystem [21][28]. Group 3: Future Goals and Initiatives - By the end of 2025, the park aims to have serviced over 600 companies and fostered the development of numerous national technology-based SMEs and high-tech enterprises [12][28]. - Plans for 2026 include deepening service offerings, such as customized financing solutions based on companies' innovation capabilities and talent [14][30]. - The Xiong'an New Area is set to host significant events and projects focused on key industries like satellite internet, artificial intelligence, and new materials, aiming for major breakthroughs in these fields [31][28].

北京海润天睿律师事务所 关于北京中关村科技发展（控股）股份有限公司 2026 年第一次临时股东会之 法律意见书 中国·北京 法律意见书 致：北京中关村科技发展（控股）股份有限公司 北京海润天睿律师事务所（以下称"本所"）受北京中关村科技发展（控股） 股份有限公司（以下称"公司"）的委托，指派本所朱卫江、齐佳惠律师（以下称 "本所律师"）出席公司 2026 年第一次临时股东会（以下称"本次股东会"），根 据《中华人民共和国证券法》（以下简称"《证券法》"）、《中华人民共和国公 司法》、《上市公司股东会规则》（以下称"《股东会规则》"）及《北京中关村 科技发展（控股）股份有限公司章程》（以下称"《公司章程》"）的规定，对本 次股东会召开的合法性进行见证，并出具法律意见书。 二〇二六年一月二十二日 北京海润天睿律师事务所 关于北京中关村科技发展（控股）股份有限公司 2026 年第一次临时股东会之 表的结论性意见合法、准确，不存在虚假记载、误导性陈述或者重大遗漏，并承 担相应法律责任。 本所律师现发表法律意见如下： 一、关于本次股东会召集和召开的程序 本所及经办律师依据《证券法》、《律师事务所从事证券法律业务管理办法 ...

2026 年第一次临时股东会决议公告 共 5 页 证券代码：000931 证券简称：中关村 公告编号：2026-014 北京中关村科技发展（控股）股份有限公司 2026 年第一次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东会没有出现否决提案的情形； 2、本次股东会不涉及变更以往股东会已通过的决议。 一、会议召开和出席情况 （一）会议召开的情况 1、召开时间： （1）现场会议时间：2026 年 1 月 22 日 14:50； （2）网络投票时间：通过深圳证券交易所交易系统进行网络投票的时间为： 2026 年 1 月 22 日 9:15-9:25、9:30-11:30 和 13:00-15:00；通过深圳证券交易所互 联网投票系统投票的时间为 2026 年 1 月 22 日 9:15 至 15:00 期间的任意时间。 2、现场会议召开地点：北京市朝阳区霄云路 26 号鹏润大厦 B 座 22 层 1 号 会议室。 3、召开方式：现场会议与网络投票相结合的方式。 4、召集人：董事会。 5、主持人：董事长许钟民先生因有其他 ...

Core Viewpoint - The company demonstrates strong confidence in its business operations, particularly in the fields of narcotic drugs and elderly care services, as discussed during a recent offline research meeting with institutional investors. Group 1: Narcotic Drug Development - The company has established a comprehensive product cluster in the narcotic pain relief sector, with a focus on the oxycodone series, which includes both raw materials and formulations [2] - The company is the only domestic pharmaceutical enterprise with an integrated advantage in oxycodone raw material and formulation, supported by 100% self-supply of raw materials and strong cost control [2] - The company disclosed that its oxycodone sustained-release tablets are in the registration review stage, with expected approvals in Q4 2026 for the 40mg version and Q3 2027 for the 10mg version [3] - The company emphasizes a unique self-operated model for promoting oxycodone sustained-release tablets, focusing on academic-driven strategies and digital penetration to enhance market coverage [3] - In the ADHD medication sector, the company utilizes a resin-controlled release microsphere technology to improve dosing precision and enhance efficacy and safety for children [3] Group 2: Elderly Care Business Optimization - The company has made significant progress in optimizing its elderly care business model, focusing on cost reduction and efficiency improvements [4] - The Nalan Garden elderly care project has implemented a three-dimensional pricing model to enhance profit contributions per bed while improving service quality and client structure [4] - The company plans to maintain high occupancy rates in community elderly care services while refining management and service quality [4] - The Taihe Ruiyuan project will launch a "trial stay experience" initiative to address the challenges of high turnover rates among elderly residents, enhancing brand promotion and occupancy conversion [5] - The company aims to adapt to changes in centralized procurement policies by focusing on differentiated products and comprehensive value competition strategies [5]

Group 1: Biopharmaceutical Segment - The biopharmaceutical segment accounts for over 80% of the company's revenue, with the strategic product, hydromorphone injection, showing continuous growth. The company aims to establish the most comprehensive hydromorphone product cluster in China, with several products in the pipeline [1][2]. - The approval timelines for hydromorphone sustained-release tablets (10mg and 40mg) are expected in Q4 2026 and Q3 2027, respectively, while acetaminophen-hydromorphone tablets are anticipated to be approved by Q2 2028 [2]. Group 2: Market Strategies - The marketing strategy for hydromorphone sustained-release tablets focuses on a self-operated model, academic-driven promotion, optimized access, tiered channel strategies, digital penetration, and compliance risk control to enhance market share and coverage [2][4]. - The acetaminophen-hydromorphone tablet market is projected to reach CNY 350-400 million by 2025, with a growth rate of approximately 20%-30%. Public healthcare accounts for over 95% of sales, with limited retail and private hospital contributions [2][3]. Group 3: Elderly Care Business - The company has implemented cost-reduction and efficiency-enhancing measures in its elderly care business, with initial positive results. Key strategies include a three-dimensional pricing model and personalized service systems to improve service value and stabilize occupancy rates [5][6]. - The company plans to maintain high occupancy rates in community projects while enhancing management and service quality. The focus will be on personalized care and service systems to boost customer satisfaction and revenue per bed [7][8]. Group 4: ADHD Medication Development - The core technological barrier for the ADHD medication methylphenidate series is the "resin-controlled release microsphere technology," which allows for precise dosage adjustments and stable drug release over 12 hours, significantly improving efficacy and safety for pediatric patients [9]. Group 5: Competitive Strategies in Drug Procurement - The company’s strategy in response to drug procurement policies includes prioritizing differentiated products, maintaining quality and cost advantages, and adapting to new procurement rules by shifting from a price-centric approach to a comprehensive value competition model [10].

Core Viewpoint - The Beijing Municipal Science and Technology Commission has announced the evaluation results for the 2025 Beijing Science and Technology Award, specifically the Outstanding Youth Zhongguancun Award, with candidate Wei Dongyi from Peking University being nominated [1][2]. Group 1: Award Details - The Outstanding Youth Zhongguancun Award is a category under the Beijing Science and Technology Award, established in August 2019, aimed at recognizing young scientists under 40 who have made significant discoveries or breakthroughs in scientific research [3]. - The award is evaluated annually, with a maximum of 30 recipients each year [3]. Group 2: Candidate Information - Wei Dongyi, a candidate for the award, has been involved in postdoctoral research at the Beijing International Center for Mathematical Research since December 2017 and has been an assistant professor at Peking University since December 2019 [2]. - Wei Dongyi is recognized for his contributions to the project "Mathematical Research on Flow Transition Mechanisms," which has passed the preliminary evaluation for the 2025 National Natural Science Award, with a suggested grade of second prize [2]. Group 3: Nominators - The nominators for Wei Dongyi include mathematicians and academicians Wen Lan and Wang Shisen, who are both leaders in their respective fields of differential dynamical systems and low-dimensional manifolds and geometric topology [2].

Core Viewpoint - The Beijing Municipal Education Commission has issued a reminder for parents to carefully select technology-related extracurricular training institutions, emphasizing the protection of their legal rights and the safety of prepaid funds [1]. Group 1: Selection Criteria for Training Institutions - Parents should verify the qualifications of training institutions by confirming the possession of an educational permit issued by the education administration and a business license or registration certificate from market regulation or civil affairs departments [1]. - It is essential for parents to sign standardized contracts based on the "Beijing Technology Extracurricular Training Service Contract (Sample Text) (Trial)" when enrolling and making payments [1]. Group 2: Fee Management and Compliance - Parents must refer to the "Beijing Technology Extracurricular Training Prepayment Management Measures (Trial)" to ensure the compliance of fee collection practices by training institutions [1]. - Institutions using prepaid fees cannot charge or indirectly collect fees exceeding three months or 60 class hours at once, and single payments should not exceed 5,000 yuan [1]. Group 3: Warning Against Unlawful Practices - Parents should refuse to pay any fees outside the publicly announced projects and standards, avoid forced fundraising, and reject payment through training loans [2]. - There have been reports of fraudsters impersonating the "National 12315 Platform" to issue refund announcements, prompting parents to verify such information through official channels and avoid clicking unknown links or transferring money to unfamiliar accounts [2].